Ezra Y. Yacob - Nov 21, 2024 Form 4 Insider Report for EOG RESOURCES INC (EOG)

Role
Chairman & CEO, Director
Signature
Michele L. Hatz, attorney-in-fact for Ezra Y. Yacob
Stock symbol
EOG
Transactions as of
Nov 21, 2024
Transactions value $
-$297,902
Form type
4
Date filed
11/25/2024, 12:00 PM
Previous filing
Nov 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOG Common Stock Options Exercise $918K +7.23K +4.04% $127.00 186K Nov 21, 2024 Direct
transaction EOG Common Stock Disposed to Issuer -$919K -6.76K -3.63% $135.98 179K Nov 21, 2024 Direct
transaction EOG Common Stock Tax liability -$25.6K -188 -0.1% $135.98 179K Nov 21, 2024 Direct
transaction EOG Common Stock Options Exercise $1.04M +12.8K +7.12% $81.81 192K Nov 21, 2024 Direct
transaction EOG Common Stock Disposed to Issuer -$1.04M -7.68K -4% $136.00 184K Nov 21, 2024 Direct
transaction EOG Common Stock Tax liability -$272K -2K -1.09% $136.00 182K Nov 21, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOG Stock Appreciation Rights Options Exercise $0 -7.23K -100% $0.00 0 Nov 21, 2024 Common Stock 7.23K $127.00 Direct F1
transaction EOG Stock Appreciation Rights Options Exercise $0 -12.8K -100% $0.00 0 Nov 21, 2024 Common Stock 12.8K $81.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 27, 2018 date of grant. The SARs granted became fully exercisable on September 27, 2021. This exercise did not involve any open-market sale of the Issuer's Common Stock.
F2 The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted became fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.